(2)Commission Implementing Regulation (EU) 2024/1749note renewed the approval of the active substance metconazole until 31 August 2031 and Commission Implementing Regulation (EU) 2025/1152note renewed the approval of the active substance quinolin-8-ol until 30 June 2032. No allocations of rapporteur Member States and co-rapporteur Member States have yet taken place for the evaluation of those two active substances. It is therefore appropriate to proceed with such allocation.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.